NIH Reporter #1R01TW013180-01

Same-Day Antiretroviral Therapy as a Behavioral Design Intervention to Reduce Stigma in Key Affected Populations

The award funds a project to develop and pilot test a behavioral design intervention using same-day antiretroviral therapy to reduce stigma among key affected populations with HIV, particularly MSM in Peru. The intervention aims to improve treatment outcomes by streamlining ART initiation and reducing stigma in healthcare settings.

Description

This research explores the development and pilot testing of an innovative behavioral design intervention by applying behavioral design to a same-day antiretroviral therapy protocol to reduce opportunities to reinforce stigma toward key-affected populations with HIV in healthcare settings. The project aims to reduce HIV-related stigma through a Behavioral Design Intervention (BDI) that utilizes same-day ART (SD-ART) protocols to streamline the treatment initiation process, focusing on MSM populations in Peru. The intervention will be pilot-tested with 125 newly diagnosed MSM to measure changes in stigma, physician trust, social support, and psychological well-being.

View original record